Butyrate mediates nucleotide-binding and oligomerisation domain (NOD) 2-dependent mucosal immune responses against peptidoglycan

European Journal of Immunology

Volumn 39, Issue 12, 2009, Pages 3529-3537

  Leung, Chung Hang ^a   Lam, Wing ^b   Ma, Dik Lung ^a   Gullen, Elizabeth A ^b   Cheng, Yung Chi ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Butyrate; Intestinal immunity; Nucleotide binding and oligomerization domains (NOD); Peptidoglycan; TLR

Indexed keywords

BUTYRIC ACID; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CHEMOKINE; HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PEPTIDOGLYCAN; PROTEIN GRO ALPHA; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIETARY FIBER; ENTERITIS; HUMAN; HUMAN CELL; IMMUNOREGULATION; INTESTINE FUNCTION; MUCOSAL IMMUNITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; UPREGULATION;

BLOTTING, WESTERN; BUTYRATES; CACO-2 CELLS; CHEMOKINE CXCL1; CHEMOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNITY, MUCOSAL; INTERLEUKIN-8; NF-KAPPA B; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; PEPTIDOGLYCAN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TOLL-LIKE RECEPTOR 2; UP-REGULATION;

EID: 73249125168     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939454     Document Type: Article

References (40)

1. Rescigno, M. and Nieuwenhuis, E. E., The role of altered microbial signaling via mutant NODs in intestinal inflammation. Curr. Opin. Gastroenterol. 2007. 23: 21-26.
2. Hruz, P. and Eckmann, L., Caspase recruitment domain-containing sensors and adaptors in intestinal innate immunity. Curr. Opin. Gastroenterol. 2008. 24: 108-114.
3. Rescigno, M., Lopatin, U. and Chieppa, M., Interactions among dendritic cells, macrophages, and epithelial cells in the gut: implications for immune tolerance. Curr. Opin. Immunol. 2008. 20: 669-675.
4. Rakoff-Nahoum, S. and Medzhitov, R., Toll-like receptors and cancer. Nat. Rev. Cancer 2009. 9: 57-63.
5. Lee, J., Mo, J. H., Katakura, K., Alkalay, I., Rucker, A. N., Liu, Y. T., Lee, H. K. et al., Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat. Cell Biol. 2006. 8: 1327-1336.
6. Korzenik, J. R. and Podolsky, D. K., Evolving knowledge and therapy of inflammatory bowel disease. Nat. Rev. Drug Discov. 2006. 5: 197-209.
7. Macdonald, T. T. and Monteleone, G., Immunity, inflammation, and allergy in the gut. Science 2005. 307: 1920-1925.
8. Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P. and Macfariane, G. T., Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987. 28: 1221-1227.
9. Wong, J. M., de Souza, R., Kendall, C. W., Emam, A. and Jenkins, D. J., Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 2006. 40: 235-243.
10. Sanderson, I. R., Dietary modulation of GALT. J. Nutr. 2007. 137: 2557S-2562S.
11. Hamer, H. M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F. J. and Brummer, R. J., Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 2008. 27: 104-119.
12. Fusunyan, R. D., Quinn, J. J., Fujimoto, M., MacDermott, R. P. and Sanderson, I. R., Butyrate switches the pattern of chemokine secretion by intestinal epithelial cells through histone acetylation. Mol. Med. 1999. 5: 631-640.
13. Saegusa, S., Totsuka, M., Kaminogawa, S. and Hosoi, T., Candida albicans and Saccharomyces cerevisiae induce interleukin-8 production from intestinal epithelial-like Caco-2 cells in the presence of butyric acid. FEMS Immunol. Med. Microbiol. 2004. 41: 227-235.
14. Weng, M., Walker, W. A. and Sanderson, I. R., Butyrate regulates the expression of pathogen-triggered IL-8 in intestinal epithelia. Pediatr. Res. 2007. 62: 542-546.
15. Malago, J. J., Koninkx, J. F., Tooten, P. C., van Liere, E. A. and van Dijk, J. E., Anti-inflammatory properties of heat shock protein 70 and butyrate on Salmonella-induced interleukin-8 secretion in enterocyte-like Caco-2 cells. Clin. Exp. Immunol. 2005. 141: 62-71.
16. Dalmasso, G., Nguyen, H. T., Yan, Y., Charrier-Hisamuddin, L., Sitaraman, S. V. and Merlin, D., Butyrate transcriptionally enhances peptide transporter PepT1 expression and activity. PLoS ONE 2008. 3: e2476.
17. Chaput, C. and Boneca, I. G., Peptidoglycan detection by mammals and flies. Microbes Infect. 2007. 9: 637-647.
18. Zähringer, U., Lindner, B., Inamura, S., Heine, H. and Alexander, C., TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 2008. 213: 205-224.
19. Travassos, L. H., Girardin, S. E., Philpott, D. J., Blanot, D., Nahori, M. A., Werts, C. and Boneca, I. G., Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 2004. 5: 1000-1006.
20. Dziarski, R. and Gupta, D., Staphylococcus aureus peptidoglycan is a Toll-like receptor 2 activator: a reevaluation. Infect. Immun. 2005. 73: 5212-5216.
21. Lee, L. F., Haskill, J. S., Mukaida, N., Matsushima, K. and Ting, J. P., Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter. Mol. Cell. Biol. 1997. 17: 5097-5105.
22. Norodi, C., Hart, J., Dhawan, P., Moon, N. S., Nepveu, A. and Richmond, A., The role of CDP in the negative regulation of CXCL1 gene expression. J. Biol. Chem. 2001. 276: 26122-26131.
23. Richmond, A., NF-kB, chemokine gene transcription and tumour growth. Nat. Rev. Immunol. 2002. 2: 664-674.
24. Candido, E. P., Reeves, R. and Davie, J. R., Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 1978. 14: 105-113.
25. Crowell, C. K., Qin, Q., Grampp, G. E., Radcliffe, R. A., Rogers, G. N. and Scheinman, R. I., Sodium butyrate alters erythropoietin glycosylation via multiple mechanisms. Biotechnol. Bioeng. 2008. 99: 201-213.
26. Strober, W., Murray, P. J., Kitani, A. and Watanabe, T., Signalling pathways and molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol. 2006. 6: 9-20.
27. Becker, C. E. and O'Neill, L. A., Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs. Semin. Immunopathol. 2007. 29: 239-248.
28. Lee, M. S. and Kim, Y. J., Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu. Rev. Biochem. 2007. 76: 447-480.
29. Wu, L., Feng, B. S., He, S. H., Zheng, P. Y., Croitoru, K. and Yang, P. C., Bacterial peptidoglycan breaks down intestinal tolerance via mast cell activation: the role of TLR2 and NOD2. Immunol. Cell Biol. 2007. 85: 538-545.
30. Moreira, L. O., El Kasmi, K. C., Smith, A. M., Finkelstein, D., Fillon, S., Kim, Y. G., Núñez, G. et al., The TLR2-MyD88-NOD2-RIPK2 signalling axis regulates a balanced pro-inflammatory and IL-10-mediated anti-inflammatory cytokine response to Gram-positive cell walls. Cell Microbiol. 2008. 10: 2067-2077.
31. Traub, S., von Aulock, S., Hartung, T. and Hermann, C., MDP and other muropeptides-direct and synergistic effects on the immune system. J. Endotoxin. Res. 2006. 12: 69-85.
32. Vavricka, S. R., Musch, M. W., Chang, J. E., Nakagawa, Y., Phanvijhitsiri, K., Waypa, T. S., Merlin, D. et al., hPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonic Caco2/bbe cells. Gastroenterology 2004. 127: 1401-1409.
33. Böcker, U., Nebe, T., Herweck, F., Holt, L., Panja, A., Jobin, C., Rossol, S. et al., Butyrate modulates intestinal epithelial cell-mediated neutrophil migration. Clin. Exp. Immunol. 2003. 131: 53-60.
34. Böcker, U., Yezerskyy, O., Feick, P., Manigold, T., Panja, A., Kalina, U., Herweck, F. et al., Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression. Int. J. Colorectal Dis. 2003. 18: 25-32.
35. Inan, M. S., Rasoulpour, R. J., Yin, L., Hubbard, A. K., Rosenberg, D. W. and Giardina, C., The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology 2000. 118: 724-734.
36. Place, R. F., Noonan, E. J. and Giardina, C., HDAC inhibition prevents NFkappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha. Biochem. Pharmacol. 2005. 70: 394-406.
37. Steinhart, A. H., Hiruki, T., Brzezinski, A. and Baker, J. P., Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial. Aliment. Pharmacol. Ther. 1996. 10: 729-736.
38. Cummings, J. H., Short chain fatty acid enemas in the treatment of distal ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 1997. 9: 149-153.
39. Breuer, R. I., Soergel, K. H., Lashner, B. A., Christ, M. L., Hanauer, S. B., Vanagunas, A., Harig, J. M. et al., Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut 1997. 40: 485-491.
40. Sanders, M. A. and Basson, M. D., Collagen IV-dependent ERK activation in human Caco-2 intestinal epithelial cells requires focal adhesion kinase. J. Biol. Chem. 2000. 275: 38040-38047.